Back
Summit Therapeutics Stock Price Chart
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
85
SMMT
Summit Therapeutics
Last Price:
26.20
Seasonality Move:
26.72%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
Summit Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.3 | Buy |
| 20-day SMA: | 16.66 | Buy |
| 50-day SMA: | 12.66 | Buy |
| 200-day SMA: | 6.49 | Buy |
| 8-day EMA: | 23.98 | Buy |
| 20-day EMA: | 18.55 | Buy |
| 50-day EMA: | 13.95 | Buy |
| 200-day EMA: | 7.85 | Buy |
Summit Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.35 | Buy |
| Relative Strength Index (14 RSI): | 80.76 | Buy |
| Chaikin Money Flow: | -10383890 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Summit Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 29.48 while SMMT 8-day simple moving average is 22.30, which is a Buy signal.
- The stock price of SMMT is 29.48 while Summit Therapeutics 20-day SMA is 16.66, which makes it a Buy.
- Summit Therapeutics 50-day simple moving average is 12.66 while SMMT share price is 29.48, making it a Buy technically.
- SMMT stock price is 29.48 and Summit Therapeutics 200-day simple moving average is 6.49, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Buy
85
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a Buy
The current Summit Therapeutics [SMMT] share price is $29.48. The Score for SMMT is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
Summit Therapeutics Stock Info
Market Cap:
21.66B
Price in USD:
29.48
Share Volume:
14.64M
Summit Therapeutics 52-Week Range
52-Week High:
33.89
52-Week Low:
1.64
Buy
85
Summit Therapeutics (SMMT)
is a Buy
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?
The Summit Therapeutics stock price is 29.48 USD today. -
Will SMMT stock go up or go down?
Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Summit Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is not overvalued.
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 29.48 while SMMT 8-day exponential moving average is 23.98, which is a Buy signal.
- The stock price of SMMT is 29.48 while Summit Therapeutics 20-day EMA is 18.55, which makes it a Buy.
- Summit Therapeutics 50-day exponential moving average is 13.95 while SMMT share price is 29.48, making it a Buy technically.
- SMMT stock price is 29.48 and Summit Therapeutics 200-day simple moving average is 7.85, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
- SMMT Moving Average Covergence Divergence (MACD) indicator is 4.35, suggesting Summit Therapeutics is a Buy
- Summit Therapeutics Relative Strength Index (RSI) is 80.76, which suggest Summit Therapeutics is overbought
- The Bollinger Bands (25) for Summit Therapeutics is ( - ), which suggest Summit Therapeutics is a Buy
- The Bollinger Bands (100) for Summit Therapeutics is ( - ), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.